The importance of multiple myeloma foundations and a patient story
Paul Richardson et al.
Information is key: why patients need to be empowered to learn about their disease
'Off the shelf' virus-specific T cells
EBMT Nurses Group: who we are and what we aim to achieve
Are IDH mutations good minimal residual disease (MRD) markers in acute myeloid leukemia (AML)?